Cognetivity Neurosciences: RichTV Analyzes the Recent Developments

At this point in time, investors have a wide range of options when it comes to gathering information about the stock market. There are blogs, websites, apps, and also platforms like YouTube which have dedicated channels that cater to retail investors. One of the more popular YouTube channels for retail investors at this point in time is RichTV Live.

The channel commands a considerable following and regularly showcases a wide range of companies on a daily basis. In a video released last week, the RichTV analyst looked into the medical technology company Cognetivity Neurosciences Ltd  (CSE:CGN) (OTCQB:CGNSF) (FWB:1UB). The medical technology space has grown at a considerable pace in recent times and it is not a surprise that it is now an area of focus for plenty of investors.

Enter Your E-mail Address To Subscribe

* indicates required

Key Analysis

However, it is also easy to see why RichTV decided to focus on the company. There was a significant announcement from the company last week that could have long-term implications about Cognetivity’s business. The company announced that it signed an agreement with Luscii healthtech BV, a Dutch telehealth company, with regards to the development of OptiMind.

OptiMind is a wellness app that is being developed by Cognetivity and the latest agreement is an important one. The Dutch company is going to make use of highly advanced cognitive measurement capabilities in order to get a better idea of the corporate wellness measures and human resources policies that have been put in place by Cognetivity.

Dr. Sina Habibi, who is the Chief Executive Officer of the company joined in the chat with the RichTV analyst and provided plenty of insights into Cognetivity.

When he was asked about the company’s aims for 2021, he said that it took Cognetivity many years to actually come up with a clinical product and now the company is going to work towards improving it at first. He went on to add that when it comes to clinical products it is necessary for the company to bring forward a ton of evidence in order to convince healthcare professionals that the product is actually effective.

Over the course of the last few years, the company has been doing exactly that. It now remains to be seen how the stock performs over the course of this week after being showcased by RichTV.

Featured image: Pixabay

Please See Disclaimer

If You Liked This Article Click To Share

Risks and Disclosure:

Information provided in this correspondence is intended solely for informational purposes and is obtained from sources believed to be reliable. While all information is believed to be reliable, it is not guaranteed by us to be accurate. Individuals should assume that all information contained on this website is not trustworthy unless verified by their own independent research. Also, because events and circumstances frequently do not occur as expected, there will likely be differences between any predictions made or suggested and the actual results.

All statements and opinions expressed are the opinions of the author and not of or its officers. The author is wholly responsible for the validity of all statements. was not involved in any aspect of the article preparation. The author was not paid by Bitrex Inc for this article. The author did not pay to publish or syndicate this article.

This article does not constitute as investment advice. Each reader is encouraged to consult with his or her individual financial advisor; any and all actions taken by a reader as a result of the information presented here is his or her own responsibility. By opening this page, each reader accepts and agrees to's terms of use and full legal disclaimer. This article is in no way a solicitation for investment. does not render general or specific investment advice. Any information on should not be considered a recommendation to buy or sell any security. does not endorse or recommend the business, products, services or securities of any company mentioned on

Futures, stocks and options trading involves substantial risk of loss and is not suitable for every investor. The valuation of futures, stocks, and options may fluctuate, and, as a result, clients may lose more than their original investment and possibly their entire investment. Any content on this website should not be relied upon as advice or construed as providing recommendations of any kind. It is your responsibility to confirm and decide which trades to make. Always consult a licensed investment professional before making any investment decision. Be extremely careful, investing in securities carries a high degree of risk; you may likely lose some or all of the investment.

Please see our full disclaimer here for additional details before making any investment decisions.